Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes New England Journal of Medicine, 2021 https://pubmed.ncbi.nlm.nih.gov/34170647/

“In this aITC, HbA1c and weight reductions were significantly greater for tirzepatide 10 and 15 mg versus semaglutide 2 mg and were similar for tirzepatide 5 mg versus semaglutide 2 mg. These findings provide comparative effectiveness insights in the absence of a head-to-head clinical trial.” Efficacy of tirzepatide 5, 10 and 15 mg versus semaglutide2 mg in patients with type 2 diabetes: An adjusted indirect treatment comparison https://dom-pubs.onlinelibrary.wiley.com/doi/pdf/10.1111/dom.14775

RESOURCES